Negotiating the Barrier of Hypoglycemia in Diabetes
- 1 January 2002
- journal article
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 15 (1) , 20-27
- https://doi.org/10.2337/diaspect.15.1.20
Abstract
Hypoglycemia is the limiting factor in the glycemic management of diabetes. It is a barrier to quality of life and even survival in the short term and to true glycemic control, with its established microvascular and potential macrovascular benefits, in the long term. Although it is possible to both improve glycemic control and minimize the risk of hypoglycemia in many patients with currently available regimens—by applying the principles of aggressive therapy and practicing hypoglycemia risk reduction—people with diabetes need treatment methods that provide glucose-regulated insulin secretion or replacement if euglycemia is to be maintained safely over a lifetime of diabetes.Keywords
This publication has 54 references indexed in Scilit:
- Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study GroupJAMA, 1996
- Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of HypoglycemiaDiabetes Care, 1994
- Alanine and Terbutaline in Treatment of Hypoglycemia in IDDMDiabetes Care, 1993
- Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yearsJournal of Internal Medicine, 1991
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitusDiabetes, 1984
- Cornstarch Therapy in Type I Glycogen-Storage DiseaseNew England Journal of Medicine, 1984
- Identification of Type I Diabetic Patients at Increased Risk for Hypoglycemia during Intensive TherapyNew England Journal of Medicine, 1983